Financial results filed for period ended September 30, 2026
INFLUX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
INFLUX Healthtech Limited submitted financial results for the period ended September 30, 2026. The provided filing does not state whether the figures are consolidated or standalone and contains no quarterly financial numbers for comparison.
No financial figures are provided, so the effect on earnings, margins, financial health, or the stock cannot be assessed.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹85.41 Cr | ₹66.76 Cr | +27.9% |
| Operating profit | ₹15.88 Cr | ₹12.98 Cr | +22.3% |
| Profit after tax | — | — | — |
| EBITDA margin | — | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.